Fig. 3From: Perceptions towards biologic and biosimilar therapy of patients with rheumatic and gastroenterological conditionsInformation sources about biologic/targeted synthetic DMARDs and how positive different sources were about these medications for rheumatology and gastroenterology patientsBack to article page